相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The sVEGFR1-i13 splice variant regulates a beta 1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
Cherine Abou Faycal et al.
BRITISH JOURNAL OF CANCER (2018)
Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
Cherine Abou-Faycal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ground rules of the pluripotency gene regulatory network
Mo Li et al.
NATURE REVIEWS GENETICS (2017)
The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
Guangxian Zhao et al.
AGING AND DISEASE (2017)
Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production
Kirsten R. Palmer et al.
BIOLOGY OF REPRODUCTION (2016)
Genetic alteration profiling of patients with resected squamous cell lung carcinomas
Dan Tao et al.
ONCOTARGET (2016)
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer
Rebecca S. Heist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M. Tolaney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
D. Zhao et al.
ONCOGENE (2015)
NOTCH Decoys That Selectively Block DLL/NOTCH or JAG/NOTCH Disrupt Angiogenesis by Unique Mechanisms to Inhibit Tumor Growth
Thaned Kangsamaksin et al.
CANCER DISCOVERY (2015)
Alternative Splicing of MBD2 Supports Self-Renewal in Human Pluripotent Stem Cells
Yu Lu et al.
CELL STEM CELL (2014)
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
Marta Larrayoz et al.
EMBO MOLECULAR MEDICINE (2014)
The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2
Xia Xu et al.
GENES & DEVELOPMENT (2014)
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing
Tetsuya Saito et al.
FEBS LETTERS (2013)
Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer
Jeffrey A. Meyerhardt et al.
PLOS ONE (2012)
Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
Stephanie Gout et al.
PLOS ONE (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
Jes-Niels Boeckel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
Shakil Ahmad et al.
VASCULAR CELL (2011)
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer
Dan G. Duda et al.
ONCOLOGIST (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia
Christie P. Thomas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
Christopher G. Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through α5β1 integrin
Sirrionetta Soro et al.
BLOOD (2008)
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
G. Merdzhanova et al.
CELL DEATH AND DIFFERENTIATION (2008)
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis
Tatsuro Yamaguchi et al.
CANCER SCIENCE (2007)
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung
Mitch Raponi et al.
CANCER RESEARCH (2006)
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort
C Salon et al.
CELL DEATH AND DIFFERENTIATION (2006)
Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types
N Ilhan et al.
CLINICAL BIOCHEMISTRY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the α5β1 integrin
A Orecchia et al.
JOURNAL OF CELL SCIENCE (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer
M Toi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
